Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis-Reference-Cited by-同舟云学术

Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis

Published:2021-09-07 Issue:10 Volume:38 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Narendra Gera,Raju Baddipadige,Verma Himanshu,Silakari Om^ORCID

Funder

Indian Council of Medical Research

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-021-01569-9.pdf

Reference47 articles.

1. Arrigoni E, Del Re M, Galimberti S, Restante G, Rofi E, Crucitta S, Baratè C, Petrini M, Danesi R, Di Paolo A. Concise review: chronic myeloid leukemia: stem cell niche and response to pharmacologic treatment. Stem Cells Transl Med. 2018. https://doi.org/10.1002/sctm.17-0175.

2. Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring. Am J Hematol. 2020. https://doi.org/10.1002/ajh.25792.

3. Cortes JE, Talpaz M, Kantarjian H. Chronic myelogenous leukemia: a review. Am J Med. 1996. https://doi.org/10.1016/s0002-9343(96)00061-7.

4. Palejwala AH, O’Connor KP, Shi H, Villeneuve L, Scordino T, Glenn CA. Chronic myeloid leukemia manifested as myeloid sarcoma: review of literature and case report. J Clin Neurosci. 2019. https://doi.org/10.1016/j.jocn.2019.04.011.

5. Hochhaus A, Breccia M, Saglio G, García-Gutiérrez V, Réa D, Janssen J, Apperley J. Expert opinion-management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors. Leukemia. 2020. https://doi.org/10.1038/s41375-020-0842-9.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling;Biochemical Pharmacology;2024-06

2. Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation;RSC Medicinal Chemistry;2024

3. ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling;2023-08-30

4. Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach;International Journal of Biological Macromolecules;2023-07

5. Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect;Clinical Pharmacokinetics;2022-09-30